Table 4 Overall and age-specific pH1N1-attributable mortality for different vaccination scenarios for R 0 1.4 and an 8-week vaccine campaign length.
Vaccination start date | Vaccination strategy | Mortality per 100,000 population (% reduction vs. None) | ||||
|---|---|---|---|---|---|---|
|  |  | All ages | 0-4 | 5-17 | 18-54 | ≥55 |
None | None | 29.6 | 8.6 | 7.4 | 10.9 | 101.1 |
24-Aug | AC | 4.1 (86) | 1.1 (87) | 1.1 (85) | 2.1 (81) | 12.7 (87) |
| Â | UC | 5.2 (82) | 1.6 (81) | 1.9 (74) | 2.0 (81) | 17.1 (83) |
| Â | PC | 5.8 (80) | 1.9 (78) | 0.1 (99) | 1.9 (83) | 21.7 (79) |
| Â | PC+ | 3.7 (87) | 1.2 (86) | 0.1 (99) | 1.4 (87) | 13.5 (87) |
28-Sep | AC | 13.7 (54) | 3.9 (54) | 4.0 (46) | 6.0 (46) | 44.4 (56) |
| Â | UC | 14.9 (50) | 4.5 (48) | 4.6 (37) | 5.7 (48) | 49.4 (51) |
| Â | PC | 11.3 (62) | 3.4 (60) | 0.9 (88) | 4.2 (62) | 40.5 (60) |
| Â | PC+ | 9.8 (67) | 3.0 (65) | 0.7 (90) | 3.6 (67) | 35.1 (65) |
26-Oct | AC | 24.4 (18) | 7.1 (18) | 6.6 (10) | 9.5 (13) | 81.7 (19) |
| Â | UC | 24.8 (16) | 7.3 (15) | 6.7 (8) | 9.3 (15) | 83.8 (17) |
| Â | PC | 24.5 (17) | 7.2 (16) | 5.1 (31) | 9.0 (18) | 84.6 (16) |
| Â | PC+ | 23.7 (20) | 7.0 (19) | 4.9 (33) | 8.7 (20) | 82.0 (19) |
23-Nov | AC | 28.7 (3) | 8.4 (3) | 7.3 (1) | 10.7 (2) | 97.9 (3) |
| Â | UC | 28.8 (3) | 8.4 (2) | 7.3 (1) | 10.7 (2) | 98.2 (3) |
| Â | PC | 29.0 (2) | 8.5 (2) | 7.1 (4) | 10.7 (2) | 99.2 (2) |
| Â | PC+ | 28.9 (2) | 8.4 (2) | 7.1 (4) | 10.7 (3) | 98.8 (2) |